Reducing Risk of Cardiovascular Disease: Optimizing Lipid-Lowering Therapy in Primary and Secondary Prevention Patients is organized by University Learning Systems (ULS).
This seminar will discuss the primary and secondary risk reduction of Cardiovascular Disease risk through optimum lipid-lowering therapy.
Additional details will be posted as soon as information is available.
|Registration Name||Category||Last Date||Price|
|Registration Fee||Regular Fee||USD 99.00|
This program in its entirety provides 5 hours (0.5 CEU) of ACPE CPE home study credit, AMA Category 2 CME, and CNE pharmacology credit.
Toll free Number
Healthcare Management +12 More
AMA PRA Category 1 Credit™ 10